DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,675,000 | +22.3% | 430,348 | +126.4% | 0.00% | 0.0% |
| Q2 2021 | $7,092,000 | -4.7% | 190,055 | -34.7% | 0.00% | 0.0% |
| Q1 2021 | $7,438,000 | +14.2% | 290,885 | -1.6% | 0.00% | 0.0% |
| Q4 2020 | $6,515,000 | +3.2% | 295,734 | -15.7% | 0.00% | 0.0% |
| Q3 2020 | $6,310,000 | -31.8% | 350,812 | -3.7% | 0.00% | -33.3% |
| Q2 2020 | $9,255,000 | +3.6% | 364,354 | -25.1% | 0.00% | -25.0% |
| Q1 2020 | $8,932,000 | +856.3% | 486,225 | +1047.7% | 0.00% | – |
| Q4 2019 | $934,000 | -38.2% | 42,367 | -70.0% | 0.00% | -100.0% |
| Q4 2018 | $1,512,000 | +30140.0% | 141,438 | +38334.2% | 0.00% | – |
| Q2 2015 | $5,000 | -99.7% | 368 | -99.4% | 0.00% | -100.0% |
| Q1 2015 | $1,512,000 | – | 62,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |